BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10483096)

  • 21. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.
    Glover TW; Berger C; Coyle J; Echo B
    Hum Genet; 1984; 67(2):136-42. PubMed ID: 6430783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal fragile sites and relationship between genetic predisposition to small cell lung cancer.
    Karadağ M; Tunca B; Ceçener G; Egeli U; Ozyardimci N; Ege E; Gözü O
    Teratog Carcinog Mutagen; 2002; 22(1):31-40. PubMed ID: 11754385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of folate sensitive and aphidicolin induced chromosomal fragile sites in familial neuroblastoma.
    Ankathil R; Kusumakumary P; Priyakumary T; Krishnan Nair M
    J Exp Clin Cancer Res; 2002 Sep; 21(3):383-8. PubMed ID: 12385582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple common fragile sites are expressed in the genome of the laboratory rat.
    Robinson TJ; Elder FF
    Chromosoma; 1987; 96(1):45-9. PubMed ID: 2963735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on three rare fragile sites. 2q13, 12q13, and 17p12 segregating in one family.
    Romain DR; Columbano-Green LM; Smythe RH; Parfitt RG; Gebbie OB; Chapman CJ
    Hum Genet; 1986 Jun; 73(2):164-70. PubMed ID: 3087860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites.
    Egeli U; Ozkan L; Tunca B; Kahraman S; Ceçener G; Ergül E; Engin K
    Head Neck; 2000 Sep; 22(6):591-8. PubMed ID: 10941161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosomal fragile site expression in dogs: I. Breed specific differences.
    Stone DM; Jacky PB; Hancock DD; Prieur DJ
    Am J Med Genet; 1991 Aug; 40(2):214-22. PubMed ID: 1910263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common fragile site expression and genetic predisposition to breast cancer.
    Ceçener G; Egeli U; Taşdelen I; Tunca B; Duman H; Kizil A
    Teratog Carcinog Mutagen; 1998; 18(6):279-91. PubMed ID: 10052563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel putative fragile sites observed in feline fibroblasts treated with aphidicolin and fluorodeoxyuridine.
    Kubo K; Matsuyama S; Sato K; Shiomi A; Ono K; Ito Y; Ohashi F; Takamori Y
    J Vet Med Sci; 1998 Jul; 60(7):809-13. PubMed ID: 9713808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate-sensitive and aphidicolin-inducible fragile sites are expressed in the genome of the domestic cat.
    Stone DM; Stephens KE; Doles J
    Cancer Genet Cytogenet; 1993 Feb; 65(2):130-4. PubMed ID: 8453598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristic chromosomal fragility of human embryonic cells exposed in vitro to aphidicolin.
    Caporossi D; Vernole P; Nicoletti B; Tedeschi B
    Hum Genet; 1995 Sep; 96(3):269-74. PubMed ID: 7649540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced expression of common fragile site with occupational exposure to pesticides.
    Sbrana I; Musio A
    Cancer Genet Cytogenet; 1995 Jul; 82(2):123-7. PubMed ID: 7664241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous unusual expression of frequency of chromosome aberrations and common fragile in human lymphocytes of colorectal cancer patients induced by Aphidicolin.
    Saxena AK; Agarwal CS; Kumar M; Srivastava AK; Singh G
    J Exp Ther Oncol; 2007; 6(2):175-9. PubMed ID: 17407975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency.
    Chary-Reddy S; Prasad VS; Ahuja YR
    Cancer Lett; 1994 Oct; 86(1):111-7. PubMed ID: 7954347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragile sites and genitourinary tumors.
    Tajara EH; Hecht BK; Lockwood D; Bixenman H; Berger CS; Sandberg AA; Hecht F
    Cancer Genet Cytogenet; 1988 Mar; 31(1):63-8. PubMed ID: 2964265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomas.
    Sokova OI; Kirichenko OP; Mukeria AF; Demidov LV; Chebotarev AN; Kopnin BP
    Cancer Genet Cytogenet; 1992 Jan; 58(1):24-8. PubMed ID: 1530833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic investigations in mentally retarded and normal males from 14 families with the fragile site at Xq28. Results of folic acid treatment on fra(X) expression.
    Nielsen KB; Tommerup N
    Hum Genet; 1984; 66(2-3):225-9. PubMed ID: 6232199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive fragile sites in fra(X) individuals.
    Jenkins EC; Lele KP; Krawczun MS; Gross AC; Duncan CJ; Brown WT
    Am J Med Genet; 1988; 30(1-2):429-34. PubMed ID: 3052066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between chemical-induced fragile sites and chromosomal breakpoints in malignant cells in children.
    Ribeiro RC; Douglass EC; Williams DL; Raimondi SC; Valentine M; Lewis S; Crist WM
    Leuk Lymphoma; 1992 Aug; 7(5-6):401-7. PubMed ID: 1493441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosome aberrations induced by aphidicolin.
    Carme F; Rosa M; Josep E
    Mutat Res; 1999 Nov; 430(1):47-53. PubMed ID: 10592317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.